Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

The study concluded that people with Lichen Planopilaris have a more diverse scalp bacteria and different metabolic pathways compared to healthy individuals.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Netherton syndrome can cause severe dehydration, infections, and growth issues in infants.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

High testosterone increases heart disease risk in women with PCOS.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Oxidative stress plays a significant role in vitiligo, and both skin and non-skin cells may be involved.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Finasteride in male rats causes liver and metabolic issues in their offspring.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Testosterone reduces heart damage and inflammation after injury.

The document concludes that managing PCOS requires a comprehensive approach, including lifestyle changes and medication, to improve symptoms and reduce health risks.

Acne patients have higher levels of mTOR in their skin, which could be linked to future metabolic disease.

Excess androgens may cause PCOS, not just be a symptom.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.